Physician

Mark Mchaney, M.D.

According to 2025 Medicare claims, Mark Mchaney, M.D. (NPI: 1972918589) practices family practice in the Manhattan, KS market, with the plurality of this provider's patient population coming from Riley, KS. This provider's primary affiliated billing organization is COTTON-O'NEIL CLINIC REVOCABLE TRUST (NPI: 1811944457; TIN: 486341644) and primary practice location at 66502-5000. Mchaney is affiliated with the Cotton-O'Neil ACO llc (ACO ID: A2506) and NPG Health Collaborative LLC (ACO ID: A3287), participating under the MSSP model.

Mchaney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 464 traditional Medicare patients, billed 6,869 HCPCS/CPT codes, and received $126,997 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,225 prescription claims across 392 beneficiaries totaling $561,706 in drug costs, led by Ozempic (Semaglutide). DME data shows 173 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,289 to $561,706. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	94	864	$23,169
2022	157	1,018	$49,949
2023	257	2,670	$87,086
2024	464	6,869	$126,997

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	51	$1,289
2016	N/R	11	$95
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	59	259	$9,435
2022	133	1,684	$104,357
2023	208	3,646	$348,519
2024	392	6,225	$561,706

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	38	$1,675
2023	11	83	$8,084
2024	N/R	173	$19,932

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	161	161	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	252	546	$80
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	161	293	$11
36415	Insertion of needle into vein for collection of blood sample	240	483	$9
85610	Blood test, clotting time	60	97	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	67	2,711	$79,921
Eliquis	Apixaban	63	3,071	$58,709
Mounjaro	Tirzepatide	44	1,400	$49,598
Descovy	Emtricitabine/Tenofov Alafenam	17	510	$36,783
Jardiance	Empagliflozin	25	1,192	$22,332

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	26	$13,273
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	33	$2,749
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	12	$818
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	12	$604
E1392	Portable oxygen concentrator, rental	Y	N/R	17	$567

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mark Mchaney, M.D.?

Tedicare shows public-source Medicare data for Mark Mchaney, M.D. (NPI 1972918589), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Mchaney, M.D. have ACO affiliation data?

Mark Mchaney, M.D. is shown with ACO affiliation data for Cotton-O'Neil ACO llc (MSSP, ACO ID A2506) and NPG Health Collaborative LLC (MSSP, ACO ID A3287).

What billing organization is linked to Mark Mchaney, M.D.?

Mark Mchaney, M.D. is linked to COTTON-O'NEIL CLINIC REVOCABLE TRUST (billing NPI 1811944457) in the available physician profile data.

Does Mark Mchaney, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.